BOTHELL, Wash., Aug. 12, 2019 /PRNewswire/ -- BioLife Solutions, Inc. BLFS ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced that representatives of the Company will be attending, exhibiting, and/or presenting at the following upcoming scientific and investor conferences:
The Bioprocessing Summit | |
August 12th-16th, 2019 | Seaport World Trade Center, Boston, MA |
21st Annual H.C. Wainwright & Co. Global Investment Conference | |
September 8th-10th, 2019 | Lotte New York Palace Hotel, New York, NY |
3rd Annual Janney Healthcare Conference | |
September 9th-10th, 2019 | The Union League Club, New York, NY |
Biotech Week Boston – Cell & Gene Therapy Bioprocessing & Commercialization | |
https://lifesciences.knect365.com/cell-therapy-bioprocessing/ | |
September 9th-12th, 2019 | Boston Convention & Exhibition Center, Boston, MA |
CAR-TCR Summit | |
September 10th-13th, 2019 | Seaport World Trade Center, Boston, MA |
ISCT North America 2019 Regional Meeting | |
September 13th-15th, 2019 | Monona Terrace Community and Convention Center, Madison, WI |
Cord Blood Connect | |
September 13th-15th, 2019 | Loews Hotel, Miami Beach, FL |
Cell and Gene Meeting on the Mesa | |
October 2nd-4th, 2019 | Park Hyatt Aviara Resort, Carlsbad, CA |
BEST Collaborative | |
http://www.bestcollaborative.org/index.php/meetings/member-meetings/oct2019-san-antonio.html | |
October 16th – 17th, 2019 | Marriott Riverwalk, San Antonio, TX |
AABB Annual Meeting | |
October 19th-22nd, 2019 | Henry B. Gonzales Convention Center, San Antonio, TX |
Stifel 2019 Healthcare Conference | |
November 19th-21st, 2019 | Lotte New York Palace Hotel, New York, NY |
TERMIS Americas | |
December 2nd-5th, 2019 | Loews Sapphire Falls Resort, Orlando, FL |
Cellular Therapies and Transfusion Medicine in Trauma and Critical Care (CTTACC) 2019 | |
December 11th – 13th, 2019 | Rancho Bernardo Inn, San Diego, CA |
About BioLife Solutions
BioLife Solutions is a leading supplier of cell and gene therapy tools. Our proprietary CryoStor® freeze media and HypoThermosol® shipping and storage media are highly valued in the regenerative medicine, biobanking and drug discovery markets. These biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death. Our recently acquired ThawSTAR® family of automated cell thawing products and evo cold chain management system reduce therapeutic and economic risk for cell and gene therapy developers by reducing the potential of administering a non-viable dose. For more information please visit www.biolifesolutions.com, and follow BioLife on Twitter.
Media & Investor Relations |
Roderick de Greef |
Chief Financial Officer |
(425) 686-6002 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/biolife-solutions-to-attend-and-present-at-upcoming-scientific-and-investor-conferences-300899746.html
SOURCE BioLife Solutions, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.